We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Systems Biology Used To Study Cellular Glycomics in White Blood Cells

By LabMedica International staff writers
Posted on 12 Nov 2008
Two recent papers have presented the results of attempts to use a systems biology approach to understand the cellular glycome. More...
The glycome represents a cell's total sugar or carbohydrate composition. It has been described as exceeding the complexity of the proteome because of the even greater diversity of the glycome's constituent carbohydrates, and is further complicated by the sheer multiplicity of possibilities in the combination and interaction of the carbohydrates with each other and with proteins.

Systems biology is a mathematical and experimental approach that focuses on whole systems of complex biological functions and interactions instead of studying individual units, such as a single gene or protein, in isolation. Investigators at the University at Buffalo (NY, USA) used this approach to examine the relationship between gene expression, glycosyltransferase activity, glycan expression, and selectin-binding function in different cell systems, including human neutrophils, undifferentiated HL-60 (human promyelocytic cells), differentiated HL-60, and HL-60 synchronized in specific growth phases. Selectins are a large family of membrane proteins that bind oligosaccharides on other cells tightly and specifically, and are involved in signal transduction across the plasma membrane.

Their results were published in two papers. The first article, which appeared in the August 26, 2008, online edition of The FASEB Journal, described the experimental techniques used to measure enzyme reaction rates involved in glycosylation, and then drew critical correlations with gene expression, enzyme kinetics, and the structures of glycans. The second paper, which was published in the October 7, 2008, online edition of the journal Bioinformatics, described a computer model that utilized the data produced by those experiments to establish a basis for predicting the structures of glycans on cell surfaces.

"Our goal is to find ways to alter carbohydrate structures or glycans on the surfaces of white blood cells,” explained senior author Dr. Sriram Neelamegham, professor of chemical and biological engineering at the University of Buffalo. "Systems biology is well suited to this research because it helps us develop the mathematical concepts to enable us to influence and enhance our understanding of how the glycome functions. This then produces clues on how we might manipulate the adhesivity of white blood cells to the blood vessel wall.”

"The data produced experimentally allows us to determine key steps in the glycome reaction network that controls the final glycan structure that appears on cells,” said Dr. Neelamegham. "This approach then provides an in silico tool that can be applied to perturb the system of interest, such as the glycosylation network.”

Related Links:
State University of New York, University at Buffalo


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.